Article info
PDFMigraine
Review
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects
- Correspondence to Dr Jason Charles Ray, Neurology, Alfred Health, Melbourne, VIC 3004, Australia; j.ray{at}alfred.org.au
Citation
Calcitonin gene related peptide in migraine: current therapeutics, future implications and potential off-target effects
Publication history
- Received July 25, 2020
- Revised November 17, 2020
- Accepted December 16, 2020
- First published January 25, 2021.
Online issue publication
January 07, 2022
Article Versions
- You are viewing the most recent version of this article.
- Previous version (7 January 2022).
- latest version (10 January 2022).
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.